Video
Dr. Laviana on novel opioid minimization protocol after urologic robotic surgery
Author(s):
"We wanted to implement an opioid minimization pathway that was easy to follow and successful,” says Aaron Laviana, MD.
Video Player is loading.
Aaron Laviana, MD, MBA, discusses the background and results of the study, “Decreased opioid use & equivalent pain score outcomes after urologic robotic surgery using a simplified opioid minimization protocol: a prospective, non-inferiority study,” which he presented at the 2022 AUA Annual Meeting (abstract MP31-02)
Laviana Assistant is a professor of Surgery and Perioperative Care at the University of Texas at Austin Dell Medical School.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Jad Chahoud, MD, on the phase 1b STELLAR-002 trial in ccRCC
Jens Bedke, MD, on efficacy of EV plus pembrolizumab across subgroups in la/mUC
Professor Dickon Hayne shares data on mitomycin plus BCG in high-risk NMIBC
Thomas Powles, MBBS, MRCP, MD, on efficacy of sasanlimab plus BCG in BCG-naïve NMIBC
Andrew Armstrong, MD, shares 5-year data on enzalutamide plus ADT in mHSPC
Professor Dickon Hayne on bladder cancer data to watch for at ASCO 2025
Andrew Armstrong, MD, previews key prostate cancer data at ASCO 2025
5 key trial insights from AUA 2025
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Related Content
